Chiesi pays $105m to license ophthalmological drug
Chiesi agrees to license Raxone from Santhera for all indications, also picking up the option to outright acquire the asset.
Archives for May 27, 2019
Heritage issues recall after products contaminated with ‘microbial growth’
Heritage announces a recall of lots of amikacin sulfate injection and prochlorperazine edisylate injection, due to evidence of selected products being non-sterile.
Amgen acquires Nuevolution after 'high-speed' development progress
Amgen acquires Nuevolution for $167m to boost its drug discovery platform, following a previous three-year collaboration.